This is a
multidisciplinary, highly innovative project focused on the development of HemaSeq
DX diagnostic kits and panels for the detection of clinically relevant
mutations in chronic lymphocytic leukemia and multiple myeloma, including the
development of software for the clinical evaluation of mutations. The goal of
this industrial development and research is a highly specific and innovative
product targeted at selected groups of patients, while using the next-generation
sequencing technique. The project outputs are also based on optical genome
mapping technology
Number: CZ. 01.1.02/ 0.0/0.0/16_084/0010310
Period: 2017 – 2020
Program: Operační program Podnikání a inovace pro
konkurenceschopnost (APLIKACE – III. Výzva – s účinnou spoluprací)
CZ– NACE: Výzkum a vývoj v oblasti biotechnologie (72.11)
Project
partner: Univerzita Palackého v Olomouci
Project
Outputs: Prototype
